期刊文献+
共找到626篇文章
< 1 2 32 >
每页显示 20 50 100
Probucol治疗高脂血症的近期临床疗效观察
1
作者 张林虎 闫爱荣 +1 位作者 刘景德 柴颖儒 《山西职工医学院学报》 CAS 1998年第3期9-11,共3页
为观察Probucol的调脂、抗动脉粥样肝硬化作用,将60例原发性高指血症患者随机分为:probucol(0.5,日二次)治疗组和Simvatatin(5mg,睡前一次)对照组各30例,治疗4周,结果:降低TC分别为18.58%、21.98%,各组内P<0.001,组间P>0.05;降... 为观察Probucol的调脂、抗动脉粥样肝硬化作用,将60例原发性高指血症患者随机分为:probucol(0.5,日二次)治疗组和Simvatatin(5mg,睡前一次)对照组各30例,治疗4周,结果:降低TC分别为18.58%、21.98%,各组内P<0.001,组间P>0.05;降低TC-HDL-C/HDL-C比值:10.98%、35.61%,组内P<0.02,P<0.001,组间P<0.001。总有效率TC:83.33%,86.67%,组间P>0.05;TC-HDL-C/HDL-C:56.67%,93.33%,组间P<0.005。其他各生化指标无显著变化.副反应尽微。结论:Probucol调脂抗动脉粥样硬化作用迅速、可靠、无明显不良反应,值得临床广泛应用。 展开更多
关键词 probucol SIMVASTATIN 原发性高脂血症 抗动脉球样硬化
全文增补中
Probucol对碱性成纤维细胞生长因子和过氧化氢促大鼠血管平滑肌细胞增殖的影响 被引量:8
2
作者 盛林 潘其兴 +4 位作者 刘亚军 于爱琴 马玉林 杨凯 YANG Kai 《中国病理生理杂志》 CAS CSCD 北大核心 2001年第6期515-518,共4页
目的 :研究probucol对bFGF和H2 O2 促大鼠血管平滑肌细胞 (VSMC)增殖的影响。方法 :采用MTT、细胞计数和 [3H]-TdR掺入法观察probucol对bFGF和H2 O2 促VSMC增殖的影响。结果 :①Probucol抑制bFGF和H2 O2 刺激VSMC增殖和DNA合成 ,且呈剂... 目的 :研究probucol对bFGF和H2 O2 促大鼠血管平滑肌细胞 (VSMC)增殖的影响。方法 :采用MTT、细胞计数和 [3H]-TdR掺入法观察probucol对bFGF和H2 O2 促VSMC增殖的影响。结果 :①Probucol抑制bFGF和H2 O2 刺激VSMC增殖和DNA合成 ,且呈剂量依赖性。Probucol+bFGF和probucol+H2 O2 组与bFGF和H2 O2 组比较 ,细胞计数、A值和 [3H]-TdR掺入量分别下降了 40 0 %、39 1%、45 5 %和 46 9%、45 0 %、39 5 % (P <0 0 5 ,P <0 0 1)。②bFGF和H2 O2 刺激前给予probucol预处理 2 4h能显著抑制VSMC增殖和DNA合成 (P <0 0 5 ) ,而bFGF和H2 O2 刺激后 2 4h给予probucol则无明显影响 (P >0 0 5 )。结论 :Probucol能显著抑制bFGF和H2 O2 刺激的VSMC增殖和DNA合成 ,但对bFGF和H2 O2 预刺激诱导的细胞增殖无抑制作用。 展开更多
关键词 普罗布可 成纤维细胞生长因子 过氧化氢 平滑肌 血管 细胞增殖
下载PDF
8羟基脱氧鸟苷在2型糖尿病大鼠肾脏的表达及Probucol的影响 被引量:5
3
作者 徐鑫 刘东方 +2 位作者 周厚地 闫纪强 龙敏 《重庆医科大学学报》 CAS CSCD 北大核心 2009年第10期1358-1361,共4页
目的:观察8-羟基脱氧鸟苷(8-hydroxy-deoxyguanosine,8-OHdG)在2型糖尿病(Diabetesmellitus,DM)模型大鼠肾脏的表达及普罗布考(Probucol)对它的影响。方法:将大鼠分为正常对照组(Normol rats,C)、DM组(Diabetic rats,D)、普罗布考治疗组... 目的:观察8-羟基脱氧鸟苷(8-hydroxy-deoxyguanosine,8-OHdG)在2型糖尿病(Diabetesmellitus,DM)模型大鼠肾脏的表达及普罗布考(Probucol)对它的影响。方法:将大鼠分为正常对照组(Normol rats,C)、DM组(Diabetic rats,D)、普罗布考治疗组(Diabetic rats treated with probucol,N),比较各组大鼠肾组织中丙二醛(Malondialdehyde,MDA)含量、超氧化物岐化酶(Superoxide dismutase,SOD)活性,和8羟基脱氧鸟苷(8-OHdG)含量,同时观察血糖、血胰岛素、肾功能和肾脏形态变化。结果:与正常组比较,DM组血液中MDA含量明显上升(P<0.05),SOD活性显著下降(P<0.05),8-OHdG增多(P<0.05),肾功能和肾脏形态受损,而普罗布考治疗组的上述表达较DM组明显改善。结论:8-OHdG在DM肾病(Diabeticnephropathy,DN)中的表达明显增加,而普罗布考可以通过抑制氧化应激反应对2型DM模型大鼠肾脏产生保护作用。 展开更多
关键词 8-羟基脱氧鸟苷(8-OHdG) 普罗布考 糖尿病肾病 氧化应激
下载PDF
Improved dissolution and oral absorption by co-grinding active drug probucol and ternary stabilizers mixtures with planetary beads-milling method 被引量:5
4
作者 Fang Li Linsen Li +6 位作者 Shaoning Wang Yan Yang Jia Li Dongchun Liu Sijie Zhang Siling Wang Hui Xu 《Asian Journal of Pharmaceutical Sciences》 SCIE CAS 2019年第6期649-657,共9页
The objective of this work is to construct a nanosuspension drug delivery system of probucol,a BCS II drug,in order to improve its dissolution and oral bioavailability.The wet milling procedure using planetary beads-m... The objective of this work is to construct a nanosuspension drug delivery system of probucol,a BCS II drug,in order to improve its dissolution and oral bioavailability.The wet milling procedure using planetary beads-milling equipment was utilized to grind the raw probucol to ultrafine nanoparticle/nanocrystal aqueous suspension that was further solidified by freeze-drying process.Cellulose derivatives of different substitution groups and molecular weights,including HPMC,HPC,and MC,were evaluated as the primary stabilizer of probucol nanosuspension.Ternary stabilizers system composed of a primary stabilizer(cellulose derivative,i.e.HPC),a nonionic surfactant(Pluronic R F68),and an anionic surfactant(SDS)was employed to obtain probucol nanosuspension of finer particle size and enhanced dissolution in aqueous media.The probucol nanosuspension with good physical stability showed no obvious change of particle size even after storing over 7 d at 4°C or 25°C.The solidified probucol nanosuspension with trehalose as the cryoprotectant showed the highest dissolution rate(>60%at 2 h)compared to other cryoprotectant.The in vivo pharmacokinetic evaluation indicated about 15-folds higher AUC value of the probucol nanosuspension compared to that of coarse probucol suspension after oral administration to rats.The probucol nanosuspension prepared by wet-milling and ternary stabilizers system may find wide applications for improving the dissolution and oral absorption of water-insoluble drugs. 展开更多
关键词 probucol NANOSUSPENSION Ternary STABILIZERS systems PLANETARY beads-milling Bioavailability
下载PDF
Probucol抑制氧化低密度脂蛋白诱导的大鼠主动脉平滑肌细胞增殖 被引量:1
5
作者 盛林 邵利娟 +4 位作者 郝琳 徐冬玲 王兴蕾 焦波 潘其兴 《中国病理生理杂志》 CAS CSCD 北大核心 2010年第3期440-445,共6页
目的:研究Probucol抑制ox-LDL诱导RASMCs增殖与信号蛋白分子ERK1/2、MKP-1、HO-1和Trx-1表达之间的关系。方法:采用MTT、流式细胞术和Western blotting观察ox-LDL刺激条件下probucol对细胞周期、细胞增殖和凋亡、ERK1/2、MKP-1、HO-1和T... 目的:研究Probucol抑制ox-LDL诱导RASMCs增殖与信号蛋白分子ERK1/2、MKP-1、HO-1和Trx-1表达之间的关系。方法:采用MTT、流式细胞术和Western blotting观察ox-LDL刺激条件下probucol对细胞周期、细胞增殖和凋亡、ERK1/2、MKP-1、HO-1和Trx-1表达的影响。结果:(1)Probucol抑制ox-LDL刺激RASMCs增殖:100μmol/Lprobucol+35mg/Lox-LDL组与35mg/Lox-LDL组比较,A值下降了34.9%(P<0.01);(2)Probucol通过使RASMCs停滞在G0/G1期和诱导细胞凋亡2种方式抑制ox-LDL刺激细胞增殖。(3)ox-LDL显著抑制MKP-1的蛋白表达,与对照组比较下降了60.0%(P<0.01),同时使p-ERK1/2表达增加了34.7%;Probucol使MKP-1蛋白表达显著增加2倍,p-ERK1/2表达降低了15.7%(P<0.01);(4)35mg/Lox-LDL使细胞内Trx-1蛋白表达下降28.9%(P<0.05),HO-1蛋白表达轻度增加(P<0.05)。与ox-LDL组比较,probucol使Trx-1蛋白表达增加了91.6%(P<0.01),HO-1表达增加31.9%(P<0.01)。结论:Probucol通过增强MKP-1和HO-1蛋白表达、抑制细胞周期运转和诱导细胞凋亡的机制抑制RASMCs增殖。 展开更多
关键词 普罗布可 氧化低密度脂蛋白 硫氧还蛋白1 血红素加氧酶1 细胞外信号调节激酶类 丝裂原 活化的蛋白激酶磷酯酶1 平滑肌细胞
下载PDF
Both Atorvastatin and Probucol Can Down-regulate BMP-2 Expression Induced by Oxidized Low Density Lipoprotein in Human Umbilical Vein Cells
6
作者 Ming Zhang, Shenghua Zhou, Liping Liu, Xuping Li, XiangQian ShenDepartment of Cardiology, The Second Xiangya Hospital, Central South University, Changsha 410011, China 《South China Journal of Cardiology》 CAS 2007年第3期152-157,共6页
Objectives Bone morphogenetic protein-2 (BMP-2) plays an key role both in vascular development and pathophysiological processes. However, the mechanisms of oxidized low density lipoprotein (ox-LDL) and combinated with... Objectives Bone morphogenetic protein-2 (BMP-2) plays an key role both in vascular development and pathophysiological processes. However, the mechanisms of oxidized low density lipoprotein (ox-LDL) and combinated with atorvastatin or probucol on BMP-2 expression are entirely unknown in human umbilical vein cells. Methods The HUVECs were treated by ox-LDL and combinated with atorvastatin, probucol. The expression of BMP-2, NF-κB65, PPARγ mRNA was examined by RT-PCR analysis and ELISA method. The MDA and SOD were detected by routine methods. Results Ox-LDL can induced BMP-2 mNRA expression, associated with NF-κB65 mNRA expression activation. Both atorvastatin and probucol can suppress BMP-2 and NF-κB65 expression induced by oxLDL and upregulate the expression of PPARγ. Furthermore, the increase of supernatant MDA levels and decrease of supernatant SOD levels resulted from oxLDL treatment can be reversed by probucol or atorvastatin. Conclusions OxLDL-induced BMP-2 mNRA expression can be suppressed by atorvastatin and probucol, which may be accomplished by activating NF-κB65 expression and upregulating the expression of PPARγ. Our findings also indicate that that BMP-2 mNRA expression includes the activation of reactive oxygen species. 展开更多
关键词 bone morphogenetic protein-2 (BMP-2) OX-LDL ATORVASTATIN probucol
下载PDF
Influence of probucol-assisted retinal photocoagulation therapy on the visual performance and serum biochemical indexes in patients with early proliferative diabetic retinopathy
7
作者 Xiao-Xia Wen De-Wen Tan +1 位作者 Teng Fang Hong-Jun Li 《Journal of Hainan Medical University》 2017年第23期140-144,共5页
Objective: To explore the influence of probucol-assisted retinal photocoagulation therapy on the visual performance and serum biochemical indexes in patients with early proliferative diabetic retinopathy. Methods: A t... Objective: To explore the influence of probucol-assisted retinal photocoagulation therapy on the visual performance and serum biochemical indexes in patients with early proliferative diabetic retinopathy. Methods: A total of 170 patients with early proliferative DR who were treated in the hospital between December 2014 and May 2017 were retrospectively analyzed and divided into the control group (n=107) who received retinal photocoagulation therapy alone and the probucol group (n=63) who received probucol-assisted retinal photocoagulation therapy. The differences in the contents of visual performance indexes as well as serum angiogenesis indexes, inflammatory mediators and oxidative stress indexes were compared between the two groups before treatment and after 6 weeks of treatment. Results: Before treatment, the differences in the levels of visual performance indexes as well as serum contents of angiogenesis indexes, inflammatory mediators and oxidative stress indexes were not statistically significant between the two groups of patients. After 6 weeks of treatment, mean vision, 30 visual acuity and 30-60 visual acuity of probucol group were higher than those of control group;serum angiogenesis indexes HIF-1, VEGF and Ang-2 contents were lower than those of control group;serum inflammatory mediators ICAM-1, IL-2, IL-23 and TNF-α contents were lower than those of control group;serum oxidative stress index MDA content was lower than that of control group whereas TAC content was higher than that of control group. Conclusion: Probucol-assisted retinal photocoagulation therapy can effectively optimize the visual performance and promote the homeostasis recovery in patients with early proliferative diabetic retinopathy. 展开更多
关键词 EARLY PROLIFERATIVE DIABETIC RETINOPATHY probucol Retinal PHOTOCOAGULATION Visual performance
下载PDF
A randomized, open-label, multicentre study to evaluate plasma atherosclerotic biomarkers in patients with type 2 diabetes mellitus and arteriosclerosis obliterans when treated with Probucol and Cilostazol 被引量:7
8
作者 Xiao-Wei Ma Xiao-Hui Guo +4 位作者 Xin-Hua Xiao Li-Xin Guo Xiao-Feng Lv Quan-Min Li Yan Gao 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2012年第3期228-236,共9页
ObjectivesTo 当在联合和 individually.MethodsIn 与 Probucol 正 Cilostazol 对待时,与类型 2 糖尿病 mellitus ( T2DM )和动脉硬化 obliteran ( ASO )在病人评估血浆动脉粥样硬化患者 biomarkers 这开标签的研究, 40-75 年的病人... ObjectivesTo 当在联合和 individually.MethodsIn 与 Probucol 正 Cilostazol 对待时,与类型 2 糖尿病 mellitus ( T2DM )和动脉硬化 obliteran ( ASO )在病人评估血浆动脉粥样硬化患者 biomarkers 这开标签的研究, 40-75 年的病人被使随机化独自收到常规治疗,或与 Cilostazol 100 mg 出价,或与 Probucol 250 mg 出价,或与两个在里面联合。端点在 12 weeks.ResultsOf 在血浆 biomarker 和安全包括了变化 200 使随机化病人, 165 为每协议并且 160 分别地为安全(QTc 间隔) 被设置。Probucol 显著地减少了全部的胆固醇(P &#x0003c;0.001 ) ,低密度的脂蛋白胆固醇(LDL-C ) ,(P = 0.01 ) ,并且高密度的脂蛋白胆固醇(高级数据链路控制)(P &#x0003c;0.001 ) 与常规治疗相比。Cilostazol 在增加高级数据链路控制是有效的(P = 0.002 ) 并且减少 triglycerides 层次(P &#x0003c;0.01 ) 与常规治疗相比。向意义的一个趋势在氧化低密度的脂蛋白为变化为独自一个的常规治疗和 Probucol 正 Cilostazol 组之间的差别被观察(Ox-LDL, P = 0.065 ) 。biomarkers 越过治疗 groups.ConclusionsWe 被发现的留下的多数上的重要效果都没证实 Ox-LDL 能是在评估 biomarkers 之中的可能的血浆动脉粥样硬化患者 biomarker,它与在现出症状之前的潜的研究以前显示出的 T2DM 和 ASO 在病人反映了 Cilostazol 正 Probucol 的合作效果。 展开更多
关键词 动脉粥样硬化 生物标志物 2型糖尿病 西洛他唑 普罗布考 治疗 患者 随机
下载PDF
Effect of probucol on insulin resistance in patients with non-diabetic chronic kidney disease 被引量:2
9
作者 Rui WANG Ri-Bao WEI Yue YANG Na WANG Meng-Jie HUANG Cui-Ming CAO Zi-Cheng WANG Guang-Yan CAI Xiang-Mei CHEN 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2015年第5期521-527,共7页
BackgroundInsulin 抵抗(红外) 根本是在场的长期的肾疾病(CKD ) 的阶段并且与 CKD 被联系前进。Probucol 能在糖尿病 mellitus (DM ) 改进红外的预后病人。试图在非糖尿病的 CKD patients.MethodsThis 在红外和肾保护上观察 probucol ... BackgroundInsulin 抵抗(红外) 根本是在场的长期的肾疾病(CKD ) 的阶段并且与 CKD 被联系前进。Probucol 能在糖尿病 mellitus (DM ) 改进红外的预后病人。试图在非糖尿病的 CKD patients.MethodsThis 在红外和肾保护上观察 probucol 的效果的这研究是一开标签, non-placebo-controlled,使随机化的学习。59 个病人的一个总数被使随机化到 probucol 组(0.5 g,两次每日) 或用 1 的控制组:1 治疗比率。红外用一个 homeostatic 模型评价被决定 -- 红外(HOMA 红外) 索引。一个 Excel 数据库被建立在星期分析后续数据 0, 12,和 24。利息的主要结果是在HOMA红外的变化,并且利息的第二等的结果是处于估计的 glomerular 过滤率( eGFR )的变化,身体团索引( BMI ),胆固醇, triglycerides ,高密度的脂蛋白( HDL ),低密度的脂蛋白( LDL ),并且 24-h 在 24 个星期以后的 probucol 组的尿 protein.ResultsThe HOMA红外索引显著地被减少( P &#x0003c ;0.001 ) 与在治疗前的价值相比(平均减少:1.45;变化:&#x02212; 2.90 到 &#x02212; 0.43 ) 。在控制组的 HOMA 红外索引增加了(平均增加:0.54;变化:&#x02212; 0.38 ~ 1.87 ) 。为利息的第二等的结果,在这二个组之间的变化也在 eGFR 展出了重要差别(P = 0.041 ) ,胆固醇(P = 0.001 ) , fasting 胰岛素(P &#x0003c;0.001 ) ,并且 fasting C 肽(P = 0.001 ).ConclusionsCompared 到血管收缩素受体 blockers 独自一个,有 probucol 的联合改善在非糖尿病的 CKD 的红外病人和延期疾病前进。 展开更多
关键词 胰岛素抵抗 普罗布考 糖尿病 肾脏病 患者 慢性 EXCEL数据库 肾小球滤过率
下载PDF
Protective effects of probucol in rats with postoperative acute renal failure
10
作者 Cheng Yang Jun Peng Xingfeng Ren 《Oncology and Translational Medicine》 2018年第2期62-67,共6页
Objective We investigated the protective effect of probucol in rats with acute renal failure caused by various ischemia-reperfusion injuries(IRIs) after surgery.Methods Forty male Sprague-Dawley rats were randomly div... Objective We investigated the protective effect of probucol in rats with acute renal failure caused by various ischemia-reperfusion injuries(IRIs) after surgery.Methods Forty male Sprague-Dawley rats were randomly divided into a sham operation group(S group), ischemia reperfusion group(IR group), probucol low-dose treatment group(probucol + IR group 1, P+ IR1 group; probucol 250 mg/kg intragastric administration daily), and probucol high-dose treatment group(P + IR2 group; probucol 500 mg/kg intragastric administration daily). Rats in the S and IR groups were intragastrically administered with warm water every day. After 1 week, the kidney IRI rat models were prepared, after which the rats were fed for another week, and blood, urine, and the kidney tissue specimens were retained. A series of biochemical indices, superoxide dismutase(SOD), and malondialdehyde in the serum and kidney tissues were detected, and pathological changes in renal tissue were observed.Results Twenty-four-hour urinary protein excretion, urinary NAGase, Cys C, blood urea nitrogen(BUN), and creatinine were significantly lower in the P + IR1 and P + IR2 groups than in the IR group(P < 0.05). Superoxide dismutase in the serum and renal tissue increased significantly, malondialdehyde decreased significantly(P < 0.05), renal pathological injury was alleviated, and the kidney index improved significantly(P < 0.05).Conclusion Probucol can relieve various types of acute renal failure in postoperative rats. 展开更多
关键词 老鼠 SPRAGUE-DAWLEY 手术 保护 生物化学 IRI 病理学
下载PDF
普罗布考联合阿托伐他汀治疗多发脑血管狭窄合并主动脉弓溃疡斑块病例报道
11
作者 王艳玲 王雪梅 《中国卒中杂志》 北大核心 2024年第2期202-206,共5页
预防卒中的发生和复发是缺血性脑血管病防治的首要任务,多发脑血管狭窄合并主动脉弓溃疡斑块的患者缺血性卒中复发的风险显著升高。本文介绍1例普罗布考联合阿托伐他汀治疗多发脑血管狭窄合并主动脉弓溃疡斑块患者的发病和治疗情况。该... 预防卒中的发生和复发是缺血性脑血管病防治的首要任务,多发脑血管狭窄合并主动脉弓溃疡斑块的患者缺血性卒中复发的风险显著升高。本文介绍1例普罗布考联合阿托伐他汀治疗多发脑血管狭窄合并主动脉弓溃疡斑块患者的发病和治疗情况。该例患者表现为轻度神经功能缺损,住院期间发现多发脑血管狭窄合并主动脉弓溃疡斑块,在序贯双联抗血小板治疗3个月后持续阿司匹林单药抗血小板治疗,并全程联合普罗布考和阿托伐他汀强化降脂、抗氧化治疗,随访25个月,无卒中复发,且各项影像学和血液学检查指标保持稳定。 展开更多
关键词 普罗布考 脑血管 主动脉弓 动脉粥样硬化 降脂 抗氧化
下载PDF
Effect of probucol on vascular remodeling due to atherosclerosis in rabbits: an intravascular ultrasound study 被引量:12
12
作者 LI Ting-ting XIE Yi +4 位作者 GUO Yuan TIAN Hong-bo ZHANG Jian-ning PENG Jie ZHANG Yun 《Chinese Medical Journal》 SCIE CAS CSCD 2011年第12期1840-1847,共8页
Background Probucol is known to reduce the development of atherosclerotic lesions, but its impact on vascular remodeling associated with de novo atherosclerosis is incompletely understood. We therefore examined the ef... Background Probucol is known to reduce the development of atherosclerotic lesions, but its impact on vascular remodeling associated with de novo atherosclerosis is incompletely understood. We therefore examined the effect of probucol on vascular remodeling in a rabbit model of established atherosclerosis. Methods Aortic atherosclerosis was induced by a combination of endothelial injury and 10 weeks' atherogenic diet. Animals were then randomized to receive the foregoing diet without or with 1% (wt/wt) probucol for 16 weeks. At the end of week 26, in vivo intravascular ultrasound, pathological, immunohistochemical and gene expression studies were performed. Results Probucol significantly decreased vessel cross-sectional area, plaque area and plaque burden without effect on lumen area. More negative remodeling and less positive remodeling occurred in the abdominal aortas of probucol group than the control group (56% vs. 21%, 18% vs. 54%, respectively, both P〈0.01). In addition, the probucol group showed a smaller mean remodeling index relative to the control group (0.93 ± 0.13 vs. 1.05 ± 0.16, P 〈0.01). Furthermore, probucol treatment decreased macrophage infiltration, inhibited apoptosis of cells within plaques, and reduced the production of matrix metalloproteinases-2, -9, cathepsin K and cathepsin S (all P 〈0.01). Conclusions These findings suggest that probucol may attenuate the enlargement of atherosclerotic vessel walls and be associated with a negative remodeling pattern without affecting the lumen size. This effect may involve inhibition of extracellular matrix degradation and prevention of apoptosis in atherosclerotic plaques. 展开更多
关键词 ARTERIOSCLEROSIS intravascular ultrasonography plaque vascular remodeling probucol
原文传递
普罗布考联合依达拉奉右莰醇对缺血性脑卒中患者血流动力学及神经功能的影响
13
作者 梁转栓 刘相勇 王丹 《实用心电学杂志》 2024年第3期264-268,273,共6页
目的探究普罗布考联合依达拉奉右莰醇对缺血性脑卒中(cerebral ischemic stroke,CIS)患者的疗效,及其对脑血流动力学和神经功能的影响。方法回顾性选取82例CIS患者为研究对象,依据不同治疗方案将其分为对照组、观察组,各41例。对照组给... 目的探究普罗布考联合依达拉奉右莰醇对缺血性脑卒中(cerebral ischemic stroke,CIS)患者的疗效,及其对脑血流动力学和神经功能的影响。方法回顾性选取82例CIS患者为研究对象,依据不同治疗方案将其分为对照组、观察组,各41例。对照组给予依达拉奉右莰醇,观察组给予依达拉奉右莰醇+普罗布考,均连续治疗14 d。比较两组的临床疗效,美国国立卫生研究院卒中量表(National Institute of Health stroke scale,NIHSS)评分,改良Barthel评分(modified Barthel index,mBI),简易精神状态检查表(mini-mental state examination,MMSE)评分,大脑中动脉平均流速、峰流速对称性差值(difference in symmetry of peak flow velocity,DVp)、平均流速对称性差值(difference in symmetry of average flow velocity,DVm)、峰流速,血清闭合蛋白、高敏C反应蛋白(hs-CRP)、基质金属蛋白酶(matrix metalloproteinase,MMP)-9、网膜素-1及不良反应的发生情况。结果治疗后观察组总有效率高于对照组(92.68%vs.75.61%,P<0.05)。治疗后观察组mBI、MMSE评分高于对照组,NIHSS评分低于对照组(P<0.01),而大脑中动脉平均流速、峰流速及网膜素-1水平均高于对照组,DVp、DVm及血清闭合蛋白、hs-CRP、MMP-9水平均低于对照组(P<0.05)。两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论普罗布考联合依达拉奉右莰醇对CIS疗效确切,可改善患者脑血流动力学,抑制炎症反应,减轻神经功能障碍,且安全性较高。 展开更多
关键词 普罗布考 依达拉奉右莰醇 缺血性脑卒中 脑血流动力学
下载PDF
普罗布考联合他汀类药物治疗颈动脉斑块的meta分析
14
作者 陈思嘉 潘培炎 +2 位作者 陈思琪 彭菲 米东华 《中国卒中杂志》 北大核心 2024年第3期299-309,共11页
目的探究普罗布考联合他汀类药物治疗颈动脉斑块的疗效。方法以“普罗布考”“他汀”“颈动脉”为中文关键词,检索中文数据库中国知网、维普网、万方数据库,以“carotid artery”“probucol”“statins”为英文关键词,检索英文数据库Pub... 目的探究普罗布考联合他汀类药物治疗颈动脉斑块的疗效。方法以“普罗布考”“他汀”“颈动脉”为中文关键词,检索中文数据库中国知网、维普网、万方数据库,以“carotid artery”“probucol”“statins”为英文关键词,检索英文数据库PubMed、Cochrane Library、Embase,筛选普罗布考联合他汀类药物治疗颈动脉斑块的随机对照试验。检索时间为数据库建立至2023年12月17日。以单用他汀类药物治疗为对照组,他汀类药物联合普罗布考治疗为联合治疗组。参照Cochrane偏倚风险评估对纳入的研究进行质量评价。主要结局指标包括颈动脉内-中膜厚度(intima-media thickness,IMT),次要结局指标包括TC水平、hs-CRP水平、卒中事件发生等。采用RevMan 5.1软件进行meta分析。结果最终纳入11项随机对照试验,共纳入3251例患者。meta分析显示,在降低I MT方面,联合治疗组优于对照组[标准化均数差(standardized mean difference,SMD)-0.93,95%CI-1.66~-0.20,P<0.001];在降低TC水平方面,联合治疗组优于对照组(SMD-1.08,95%CI-1.60~-0.55,P<0.001);在降低hs-CRP水平方面,两组差异无统计学意义(SMD-1.22,95%CI-2.48~0.04,P=0.060);在减少卒中事件发生方面,联合治疗组优于对照组(RR 0.34,95%CI 0.17~0.65,P=0.001)。结论普罗布考联合他汀类药物治疗颈动脉斑块疗效更优,可降低患者的TC水平,并减少卒中事件发生。 展开更多
关键词 普罗布考 他汀 颈动脉斑块 颈动脉内-中膜厚度 缺血性卒中
下载PDF
Effect of probucol on autophagy and apoptosis in the penile tissue of streptozotocin-induced diabetic rats 被引量:2
15
作者 Ke-Qin Zhang Tao Tian +2 位作者 Liang-Liang Hu Hao-Ran Wang Qiang Fu 《Asian Journal of Andrology》 SCIE CAS CSCD 2020年第4期409-413,共5页
Autophagy and apoptosis have been regarded as important processes in the development of diabetic erectile dysfunction(DMED).Probucol is considered to have anti-apoptotic effects,but its relationship with autophagy has... Autophagy and apoptosis have been regarded as important processes in the development of diabetic erectile dysfunction(DMED).Probucol is considered to have anti-apoptotic effects,but its relationship with autophagy has not been reported.The aim of this study was to investigate the effects and mechanisms of probucol on erectile function.Thirty Sprague–Dawley(SD)male rats(12 weeks old)were fasted for 12 h.Twenty SD rats were injected with a single intraperitoneal injection of 60 mg kg−1 streptozotocin(STZ).Ten rats were given vehicle only and used as a sham group.After 72 h,20 STZ-treated rats with random blood glucose concentrations consistently greater than 16.7 mmol l^−1 were used as successfully established diabetic rats.The diabetic rats were divided randomly into two groups and treated with a daily gavage of probucol at a dose of 0 or 500 mg kg^−1 for 12 weeks.After treatment,the intracavernous pressure(ICP)was used to measure erectile function upon electrical stimulation of the cavernous nerve.After euthanasia,penile tissue was examined using immunohistochemistry and Western blot to assess the protein levels of B-cell lymphoma-2(Bcl-2),BCL2-associated X(Bax),microtubule-associated protein light chain 3-II(LC3-II),mammalian target of rapamycin(mTOR),and sequestosome 1(P62).Caspase-3 activity was measured to determine apoptosis using a caspase-3 assay kit.After 12 weeks of treatment,the erectile function of the probucol group was significantly better than that of the DM group(P<0.05).Bax and LC3-II protein expression and caspase-3 activity were significantly lower in the probucol group than those in the DM group(all P<0.05),while Bcl-2,mTOR,and P62 protein expression levels were significantly higher than those in the DM group(all P<0.05).We demonstrated that probucol inhibited apoptosis and autophagy in STZ-induced diabetic rats. 展开更多
关键词 APOPTOSIS AUTOPHAGY erectile dysfunction probucol
原文传递
阿加曲班联合普罗布考治疗进展性卒中患者效果及对炎症因子、促动脉硬化指数的影响
16
作者 张曼 张三军 齐琳 《青岛医药卫生》 2024年第3期161-165,共5页
目的 探讨阿加曲班联合普罗布考治疗进展性卒中的临床疗效,并分析其对炎症因子、促动脉硬化指数(AIP)、血小板功能的影响。方法 回顾性选取2019年10月至2022年10月进展性卒中患者80例,依据治疗方案不同分为单一组40例(普罗布考治疗)、... 目的 探讨阿加曲班联合普罗布考治疗进展性卒中的临床疗效,并分析其对炎症因子、促动脉硬化指数(AIP)、血小板功能的影响。方法 回顾性选取2019年10月至2022年10月进展性卒中患者80例,依据治疗方案不同分为单一组40例(普罗布考治疗)、联合组40例(阿加曲班联合普罗布考治疗)。比较两组临床疗效、安全性及治疗前后美国国立卫生研究院卒中量表(NIHSS)评分、Barthel指数评定量表(BI)评分、促动脉硬化指数(AIP)、神经功能[B型利钠肽(BNP)、神经元特异性烯醇化酶(NSE)、β淀粉样蛋白-1-42(Aβ1-42)]、炎症因子[白细胞介素-1β(IL-1β)、单核细胞趋化蛋白-1(MCP-1)、脂蛋白相关磷脂酶A2(Lp-PLA2)]、血小板功能。结果 联合组临床疗效优于单一组(P<0.05);不良反应对比无明显差异(P>0.05);与单一组比较,联合组治疗后NIHSS评分、AIP降低,BI评分升高(P<0.05);与单一组比较,联合组治疗后血清BNP、NSE、Aβ1-42、IL-1β、MCP-1、Lp-PLA2水平降低(P<0.05);与单一组比较,联合组治疗后血小板聚集率、血小板体积降低(P<0.05)。结论 阿加曲班联合普罗布考治疗进展性卒中的疗效确切,可改善神经功能、动脉粥样硬化,提高日常生活能力,减轻炎症反应程度,抑制血小板活化,且具有一定安全性。 展开更多
关键词 进展性卒中 阿加曲班 普罗布考 炎症因子 促动脉硬化指数
下载PDF
康复运动疗法与药物配合治疗缺血性脑卒中的临床效果
17
作者 李干干 郭迪 +1 位作者 武丹 孙永琨 《临床医学工程》 2024年第5期567-568,共2页
目的探讨康复运动疗法与药物配合治疗缺血性脑卒中的临床效果。方法将2021年1月至2023年1月收治的110例缺血性脑卒中患者随机分为对照组(n=55)和观察组(n=55)。对照组采用阿托伐他汀联合普罗布考治疗,观察组在对照组的基础上采用康复运... 目的探讨康复运动疗法与药物配合治疗缺血性脑卒中的临床效果。方法将2021年1月至2023年1月收治的110例缺血性脑卒中患者随机分为对照组(n=55)和观察组(n=55)。对照组采用阿托伐他汀联合普罗布考治疗,观察组在对照组的基础上采用康复运动疗法。比较两组的治疗效果、肢体运动功能及生活自理能力。结果观察组治疗总有效率为96.36%,明显高于对照组的80.00%(P<0.05)。治疗后,两组的FMA、ADL评分均升高,且观察组FMA、ADL评分高于对照组(P<0.05)。结论康复运动疗法与药物配合治疗缺血性脑卒中效果显著,可明显提高患者肢体运动能力与生活自理能力,值得临床推广应用。 展开更多
关键词 康复运动疗法 阿托伐他汀 普罗布考 缺血性脑卒中 治疗效果
下载PDF
普罗布考联合阿加曲班对穿支动脉脑梗死患者NIHSS、BI评分及凝血功能的影响
18
作者 董夏青 李志朋 赵婷 《四川生理科学杂志》 2024年第6期1320-1323,共4页
目的:回顾性分析普罗布考联合阿加曲班治疗穿支动脉脑梗死(Perfora artery cerebral infarction,PACI)疗效。方法:根据不同治疗方案将我院2021年9月至2023年6月收治的208例PACI患者分为两组,各104例,对照组给予阿加曲班(起始剂量60 mg&#... 目的:回顾性分析普罗布考联合阿加曲班治疗穿支动脉脑梗死(Perfora artery cerebral infarction,PACI)疗效。方法:根据不同治疗方案将我院2021年9月至2023年6月收治的208例PACI患者分为两组,各104例,对照组给予阿加曲班(起始剂量60 mg·d^(-1)持续24 h静脉滴注,第3 d调整剂量10 mg·次^(-1),持续3 h静脉滴注,2次·d^(-1)),联合组给予对照组加用普罗布考(250 mg·次^(-1),口服,2次·d^(-1))治疗。治疗7 d后,采用高速全自动凝血测试仪检测凝血酶原时间(Prothrombin time,PT)、活化部分凝血活酶时间(Activated partial thromboplastin time,APTT)、D-二聚体(D-dimer,D-D)、纤维蛋白原(Fibrinogen,FIB);荧光定量逆转录聚合酶链反应技术(Polymerase chain reaction,PCR)检测核苷酸结合寡聚化结构域样受体蛋白3(Nucleotide-binding oligomerization domain-like receptor protein 3,NLRP3)、半胱氨酸天冬氨酸蛋白水解酶1(Cysteinyl aspartate specific proteinase 1,Caspase-1)、白细胞介素1β(Interleukin-1β,IL-1β)的信使核糖核酸(messenger RNA,mRNA)表达量,采用美国国立卫生院卒中量表(National Institutes of Health Stroke Scale,NIHSS)评估神经功能;采用Barthel指数(Barthel index,BI)评估生活质量。结果:联合组总有效率高于对照组(P<0.05);治疗后联合组PT、APTT高于对照组,D-D、FIB及NLRP3、Caspase-1、IL-1βmRNA水平低于对照组(P<0.05);两组不良反应发生率相比,差异无统计学意义(P>0.05)。结论:阿加曲班联合普罗布考治疗PACI疗效更佳。 展开更多
关键词 普罗布考 阿加曲班 穿支动脉脑梗死 凝血功能 神经功能
下载PDF
Antioxidation of probucol in rats with experimental atherosclerosis
19
作者 赵雯娜 陈作元 董晓楠 《South China Journal of Cardiology》 CAS 2012年第4期258-263,共6页
Background Oxidative stress plays an important role in atherogenesis, which raises the possibility of using antioxidants to ameliorate atherosclerosis. In this research, we aim to determine the effects of probucol on ... Background Oxidative stress plays an important role in atherogenesis, which raises the possibility of using antioxidants to ameliorate atherosclerosis. In this research, we aim to determine the effects of probucol on atherosclerosis in rats. Methods Forty-five male adult Wistar rats were randomly and equally allocated to three groups, control group (Group N), model group (Group M) and probucol group (Group P). High-lipid diet and intraperitoneal injection of Vitamin D3 were given to establish rats atherosclerosis (AS) model. Group P was intragastrically administered Probucol after 8 weeks. At the end of 16 weeks, all the rats were weighted and sacrificed for detecting the levels of triglycerides (TG), total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein (HDL), oxidized low-density lipoprotein (OX-LDL) and malonaldehyde (MDA) in serum and the activity of serum superoxide dismutase (SOD). The histomorphologieal changes of the aorta were observed under light microscope. Results The body weight of rats in Group M and Group P were lighter than that in Group N (P 〈 0.01), and rats in Group P were heavier than those in Group M (P 〈 0.01). The contents of TC, TG and LDL-C in serum were obviously elevated in Group M and Group P compared with those in Group N (P 〈 0.01), and the content of HDL in Groups M and P was lower than that in Group N (P 〈 0.01). The contents of TC and LDL-C in serum were significantly lower in Group P than those in Group M (P 〈 0.01 ). However, the contents of TG and HDL in Groups M and P showed no statistically significant differences with each other (P 〉 0.05). The serum OX-LDL and MDA levels significantly increased, SOD activity decreased in Groups M and P compared with Group N (P 〈 0.01), while the levels of OX-LDL and MDA in Group P were lower than those in Group M (P 〈 0.05). No vessel lesion was found in Group N. The endothelial damage of the aorta was more significantly severe in Group M than in Group N, while the vessel lesion was less severe in Group P than in Group M. Conclusion Probucol can prevent atherogenesis and play a crucial role in inhibition of oxidative stress. 展开更多
关键词 ATHEROSCLEROSIS probucol RATS oxidative stress
原文传递
普罗布考联合匹伐他汀治疗老年高血压合并脑梗死恢复期的疗效及对患者颈动脉斑块、血脂和血清炎症因子水平的影响 被引量:1
20
作者 黄攀登 董利平 +5 位作者 郭美丹 刘杨杨 席晓霞 高云鹰 吴佳宏 崔玉环 《临床和实验医学杂志》 2023年第24期2577-2581,共5页
目的探讨普罗布考联合匹伐他汀治疗老年高血压合并脑梗死恢复期的临床疗效以及其对患者颈动脉斑块、血脂和血清炎症因子水平的影响。方法前瞻性选取2020年6月至2021年6月河北北方学院附属第一医院收治的100例老年高血压合并脑梗死恢复... 目的探讨普罗布考联合匹伐他汀治疗老年高血压合并脑梗死恢复期的临床疗效以及其对患者颈动脉斑块、血脂和血清炎症因子水平的影响。方法前瞻性选取2020年6月至2021年6月河北北方学院附属第一医院收治的100例老年高血压合并脑梗死恢复期患者,以随机数字表法将其分为观察组(n=50)和对照组(n=50)。对照组口服匹伐他汀钙片(1 mg/次,1次/d)治疗,观察组在此基础上口服普罗布考片(0.25 g/次,2次/d)治疗。两组均连续治疗6个月。观察两组的疗效,比较两组治疗前、治疗6个月后的颈动脉斑块相关指标、血脂[总胆固醇、低密度脂蛋白胆固醇(LDL-C)和甘油三酯]、血清炎症因子[超敏C反应蛋白(hs-CRP)、基质金属蛋白酶-9(MMP-9)、肿瘤坏死因子α(TNF-α)、白细胞介素(IL)-6]水平,并记录两组药物不良反应情况。结果观察组总有效率为90.00%,较对照组(74.00%)显著升高,差异有统计学意义(P<0.05)。治疗6个月后,两组的颈动脉斑块面积均较治疗前显著缩小,颈动脉IMT和斑块总积分均较治疗前显著降低,且观察组颈动脉斑块面积为(16.85±4.38)mm^(2),显著小于对照组[(22.47±6.29)mm^(2)],IMT及斑块总积分分别为(0.96±0.15)mm、(3.71±1.16)分,均低于对照组[(1.13±0.17)mm、(4.28±1.30)分],差异均有统计学意义(P<0.05)。治疗6个月后,两组的血清总胆固醇、LDL-C、甘油三酯、hs-CRP、MMP-9、TNF-α及IL-6水平均较治疗前降低,且观察组血清总胆固醇、LDL-C、甘油三酯、hs-CRP、MMP-9、TNF-α及IL-6水平分别为(4.36±0.55)mmol/L、(2.69±0.36)mmol/L、(1.23±0.31)mmol/L、(1.08±0.29)mg/L、(187.62±35.73)μg/L、(22.58±6.72)pg/mL、(9.34±2.26)pg/mL,均显著低于对照组[(4.79±0.63)mmol/L、(3.17±0.47)mmol/L、(1.46±0.34)mmol/L、(1.54±0.41)mg/L、(203.88±42.39)μg/L、(29.36±8.47)pg/mL、(11.53±2.87)pg/mL],差异均有统计学意义(P<0.05)。观察组的不良反应发生率为8.00%,与对照组(4.00%),差异无统计学意义(P>0.05)。结论普罗布考联合匹伐他汀对老年高血压合并脑梗死恢复期患者具有确切的临床疗效,是消减颈动脉粥样硬化斑块的安全有效途径,其作用可能与显著改善血脂异常、下调血清相关炎症因子的表达水平有关。 展开更多
关键词 高血压合并脑梗死 老年人 普罗布考 匹伐他汀 颈动脉斑块 血脂 炎症反应
下载PDF
上一页 1 2 32 下一页 到第
使用帮助 返回顶部